163
Participants
Start Date
December 31, 2011
Primary Completion Date
May 31, 2014
Study Completion Date
July 31, 2014
Ceftaroline fosamil
"Subjects ≥ 6 months old: 12 mg/kg IV for subjects weighing ≤ 33 kg and 400 mg for subjects weighing \> 33 kg will be infused over 60 (± 10) minutes every 8 hours (q8h) (± 1 hour)~Subjects \< 6 months old: 8mg/kg infused over 60 (± 10) minutes every 8 hours (q8h) (± 1 hour)"
Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam
"Vancomycin 15mg/kg IV over 60 minutes (or a maximum of 10mg/min whichever is longer) +/- Aztreonam 30 mg/kg IV every 8 hours over 60 minutes (for infections involving gram negative pathogen suspected or confirmed)~Cefazolin 75mg/kg IV divided every 8 hours over 60 minutes (for sites that do not empirically cover for MRSA) +/- Aztreonam 30 mg/kg IV every 8 hours over 60 minutes (for infections involving gram negative pathogen suspected or confirmed"
Cephalexin or Clindamycin or Linezolid
"Possible oral switch on or after study day 4.~Cephalexin: 25 mg/kg q6h PO or Clindamycin: 10 mg/kg q8h PO or Linezolid 600mg q12h (cohort 1) or 10 mg/kg q8h (cohorts 2,3 and 4) PO."
Investigational Site - Phoenix, Phoenix
Investigational Site - Orange, Orange
Investigational Site - San Diego, San Diego
Investigational Site - Jacksonville, Jacksonville
Investigational Site - Atlanta, Atlanta
Investigational Site - Chicago 1, Chicago
Investigational Site - Chicago 2, Chicago
Investigational Site - Springfield, Springfield
Investigational Site - Shreveport, Shreveport
Investigational Site - Baltimore, Baltimore
Investigational Site - Detroit, Detroit
Investigational Site - Brooklyn, Brooklyn
Investigational Site - New Hyde Park, New Hyde Park
Investigational Site - Rochester, Rochester
Investigational Site - Bronx, The Bronx
Investigational Site - Akron, Akron
Investigational Site - Cleveland 1, Cleveland
Investigational Site - Cleveland 2, Cleveland
Investigational Site - Toledo, Toledo
Investigational Site - Pittsburgh, Pittsburgh
Investigational Site - Charleston, Charleston
Investigational Site - Memphis, Memphis
Investigational Site - Austin 1, Austin
Investigational Site - Fort Worth, Fort Worth
Investigational Site - Norfolk, Norfolk
Investigational Site - Richmond, Richmond
Investigational Site - Seattle, Seattle
Investigational Site - Morgantown, Morgantown
Investigational Site - Buenos Aires 1, Buenos Aires
Investigational Site - Buenos Aires 2, Buenos Aires
Investigational Site - Buenos Aires 3, Buenos Aires
Investigational Site - Buenos Aires 4, Buenos Aires
Investigational Site - Buenos Aires 5, Buenos Aires
Investigational Site - Buenos Aires 6, Buenos Aires
Investigational Site - Santa Fe 1, Santa Fe
Investigational Site - Santa Fe 2, Santa Fe
Investigational Site - Puente Alto, Puente Alto
Investigational Site - San Ramon, San Ramón
Investigational Site - Vitacura, Vitacura
Investigational Site - Vina Del Mar, Viña del Mar
Investigational Site - Tbilisi 1, Tbilisi
Investigational Site - Tbilisi 2, Tbilisi
Investigational Site - Daugavpils, Daugavpils
Investigational Site - Liepaja, Liepāja
Investigational Site - Rezekne, Rēzekne
Investigational Site - Riga, Riga
Investigational Site - Kaunas, Kaunas
Investigational Site - Vilnius, Vilnius
Investigational Site - Bydgoszcz 1, Bydgoszcz
Investigational Site - Bydgoszcz 2, Bydgoszcz
Investigational Site - Lodz, Lodz
Investigational Site - Lublin, Lublin
Investigational Site - Rzeszow, Rzeszów
Investigational Site - Warszawa, Warsaw
Investigational Site - Bucharest 1, Bucharest
Investigational Site - Bucharest 2, Bucharest
Investigational Site - Constanta, Constanța
Investigational Site - Tirgu Mures, Târgu Mureş
Investigational Site - Timisoara, Timișoara
Investigational Site - Cape Town 1, Cape Town
Investigational Site - Cape Town 2, Cape Town
Investigational Site - Cape Town 3, Cape Town
Investigational Site - Johannesburg, Johannesburg
Investigational Site - Badalona, Badalona
Investigational Site - Esplugues de Llobregat, Esplugues de Llobregat
Investigational Site - Getafe, Getafe
Investigational Site - Madrid 1, Madrid
Investigational Site - Madrid 2, Madrid
Investigational Site - Madrid 3, Madrid
Investigational Site - Santiago de Compostela, Santiago de Compostela
Investigational Site - Valencia, Valencia
Lead Sponsor
Collaborators (1)
AstraZeneca
INDUSTRY
Forest Laboratories
INDUSTRY